BioCentury
ARTICLE | Clinical News

PVAC: Started Phase II trials

January 17, 2000 8:00 AM UTC

Corixa Corp. (CRXA), Seattle, Wash. Product: PVAC Business: Autoimmune/Inflammation Therapeutic category: Immune modulation Target: Immune system Description: Heat-killed Mycobacterium vaccae extract...